Senti Biosciences Holdings
SNTI
15 hedge funds and large institutions have $5.84M invested in Senti Biosciences Holdings in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.06% less ownership
Funds ownership: 22.41% → 21.35% (-1.1%)
6% less funds holding
Funds holding: 16 → 15 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
29% less capital invested
Capital invested by funds: $8.27M → $5.84M (-$2.43M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$78.5K |
| 2 |
Jane Street
New York
|
+$67.9K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.01K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
8GI
8VC GP I
Austin,
Texas
|
-$358K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$117K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$37.5K |
| 4 |
Two Sigma Investments
New York
|
-$22.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$14.2K |
SNTI Hedge Fund Activity: Q4 2025 in Review
15 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q4 2025, worth a combined $5.84M — down 29% from $8.27M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SNTI and 4 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $78.5K. The largest seller was 8VC GP I, exiting entirely with an estimated $358K sold.
- 15 institutional investors held Senti Biosciences Holdings (SNTI) as of Q4 2025, down from 16 in Q3 2025.
- Funds reported $5.84M of Senti Biosciences Holdings stock for Q4 2025, down 29% quarter-over-quarter.
- 4 funds opened new Senti Biosciences Holdings positions in Q4 2025 and 5 closed out, a net change of -1 holder.
- The largest Senti Biosciences Holdings buyer in Q4 2025 was Virtu Financial, an estimated $78.5K added.
- The largest Senti Biosciences Holdings seller in Q4 2025 was 8VC GP I, an estimated $358K sold.
Based on aggregated 13F filings for Q4 2025.